Company Monitoring Page for AbbVie

latest headlines for company on cafepharma

Harvoni’s New Label Gives Gilead Edge Over AbbVie
Bidness, ETC
Wed, 02/17/16 - 10:42 am
Tags:
Harvoni, labeling, Gilead Sciences, AbbVie, Viekira Pak, hepatitis C
AbbVie and Gilead Sciences Lead 2015 Drug Sales with Humira & Harvoni
Bidness, ETC
Thu, 02/11/16 - 09:01 pm
Tags:
AbbVie, Gilead Sciences, Humira, Harvoni
AbbVie, Maker of World's No. 1 Drug, Bets Synthetic Biology Startup Can Raise the Bar
Forbes
Wed, 02/10/16 - 09:39 am
Tags:
AbbVie, Synlogic, R&D, inflammatory bowel disease
Is the Anti-TNF Lead of AbbVie, Amgen, JNJ Nearing an End?
Bidness, ETC
Mon, 02/8/16 - 11:01 am
Tags:
AbbVie, Amgen, JNJ, anti-TNF, Remicade
Seven $1 billion-plus drugs seen reaching market in 2016
Yahoo/Reuters
Thu, 02/4/16 - 09:29 am
Tags:
Intercept Pharmaceuticals, Gilead Sciences, Roche, AbbVie, Merck, obeticholic acid, emtricitabine
Forget Biosimilars: It's This Threat That Could Dent AbbVie's Top Line
Motley Fool
Sun, 01/31/16 - 01:37 pm
Tags:
AbbVie, biosimilars, Humira, baricitinib, rheumatoid arthritis, Incyte, Eli Lilly
AbbVie beats fourth-quarter profit expectations
Marketwatch
Fri, 01/29/16 - 10:25 am
Tags:
AbbVie, earnings
AbbVie Inc 4Q Earnings: What to Expect AbbVie Inc 4Q Earnings: What to Expect
Bidness, ETC
Thu, 01/28/16 - 09:00 pm
Tags:
AbbVie, earnings
Amgen's Humira biosim is one step closer to FDA approval. But how close is it to market?
Fierce Pharma
Tue, 01/26/16 - 09:01 pm
Tags:
Amgen, biosimilars, Humira, FDA, AbbVie
AbbVie’s Net Profit Margin Expected to Reach 29.8% in 4Q15
Yahoo/Market Realist
Tue, 01/26/16 - 09:15 am
Tags:
AbbVie, earnings
US Big Pharma: What To Watch For In Q4 Results
Yahoo/Benzinga
Mon, 01/25/16 - 10:20 pm
Tags:
earnings, Eli Lilly, JNJ, Bristol-Myers Squibb, AbbVie, Pfizer, Merck
Galapagos moves AbbVie-partnered drug into PhI as multipronged attack on CF takes shape
Fierce Biotech
Sat, 01/23/16 - 11:06 am
Tags:
Galapagos, AbbVie, GLPG2222, cystic fibrosis
AbbVie Expects Imbruvica Revenues to Reach $5 Billion in 2020
Yahoo/Market Realist
Wed, 01/20/16 - 09:27 pm
Tags:
AbbVie, Imbruvica, blood cancers
3 Scorned Biotechs Destined to Rebound
TheStreet.com
Wed, 01/20/16 - 10:25 am
Tags:
Merrimack Pharmaceuticals, Relypsa, Amgen, AbbVie, Dynavax
3 Slides That Perfectly Sum Up Where AbbVie Is Headed Next
Motley Fool
Tue, 01/19/16 - 04:24 pm
Tags:
AbbVie, Humira, Imbruvica, Viekira Pak
AbbVie Is Expected to Strengthen Its Position in Virology in 4Q15
Yahoo/Market Realist
Tue, 01/19/16 - 09:28 am
Tags:
AbbVie, hepatitis C, Lupron, Duodopa, Creon, Viekira Pak
AbbVie's Management Just Made Some Pretty Bold Predictions
Motley Fool
Sun, 01/17/16 - 12:18 pm
Tags:
AbbVie, Humira, Viekira Pak
U.S. patent office rules against Amgen Humira challenge
Yahoo/Reuters
Thu, 01/14/16 - 08:49 pm
Tags:
patents, Amgen, Humira, generics, AbbVie
Roche and AbbVie line up for quick approval for cancer drug venetoclax
Fierce Biotech
Tue, 01/12/16 - 09:19 pm
Tags:
AbbVie, Roche, venetoclax, chronic lymphocytic leukemia
Biosimilars Are Coming After Big Pharma's Bottom Line
Fortune
Tue, 01/12/16 - 02:37 pm
Tags:
Big Pharma, biosimilars, Roche, AbbVie, MabThera, Herceptin, Avastin, Humira, Janssen, Remicade

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.